PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.50%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-25.93%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.41%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-23.20%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-22.73%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.73%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.67%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
105.66%
Positive OCF growth while AR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
32.76%
Positive FCF growth while AR is negative. John Neff would see a strong competitive edge in net cash generation.
-83.97%
Negative 10Y revenue/share CAGR while AR stands at 1095.02%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
12.11%
5Y revenue/share CAGR under 50% of AR's 1095.02%. Michael Burry would suspect a significant competitive gap or product weakness.
-48.06%
Negative 3Y CAGR while AR stands at 24.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-91.64%
Negative 10Y OCF/share CAGR while AR stands at 245.78%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-73.86%
Negative 5Y OCF/share CAGR while AR is at 245.78%. Joel Greenblatt would question the firm’s operational model or cost structure.
-78.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-80.99%
Negative 10Y net income/share CAGR while AR is at 99.11%. Joel Greenblatt sees a major red flag in long-term profit erosion.
116.90%
5Y net income/share CAGR 1.25-1.5x AR's 99.11%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-6.98%
Negative 3Y CAGR while AR is 89.93%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-69.39%
Negative equity/share CAGR over 10 years while AR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.92%
Negative 5Y equity/share growth while AR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-24.12%
Negative 3Y equity/share growth while AR is at 80.46%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-92.29%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-92.79%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-78.68%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.14%
Our AR growth while AR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
2.14%
Asset growth at 50-75% of AR's 3.72%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.95%
BV/share growth above 1.5x AR's 0.45%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.30%
Debt shrinking faster vs. AR's 10.82%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-14.81%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.